Welcome Message


On behalf of the Executive Committee of the International College of Neuropsychopharmacology (CINP) and our partner organization, the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN), it is my pleasure to invite you to the 33rd CINP World Congress of Neuropharmacology.

Due to the continued global presence of COVID-19 and the uncertainty for large gatherings, international travel and being granted leave, the CINP World Congress will be delivered in a hybrid format, with a mixture of in-person presentations in Taipei, Taiwan and virtual presentations from those who are unable to travel to Taiwan in June 2022.

This upcoming World Congress welcomes delegates from all over the globe to join us virtually or in the beautiful city of Taipei to carry on the momentum of the previous World Congresses. Building on our previous efforts, we will expand our core mission of linking the advances in brain sciences to the alleviation of the distress and disabilities associated with neuropsychiatric disorders. With advances in neuroscience, this is an exciting time for the understanding of psychiatric pathophysiology and the 33rd CINP Hybrid World Congress will feature the most up-to-date research, diverse topics of interest, and educational sessions with leading experts.

We hope that you will be able to join us to advance the research and education of psychopharmacology.


Professor Pierre Blier
CINP President (2021-2022)

Important Dates


Call for Symposia 19 July 2021
Symposia Submission Deadline 10 October 2021
Symposia Acceptance Notification 19 November 2021
Call for Abstracts Week of 10 January 2022
Registration Open 31 January 2022
Abstract Submission Deadline (Extended) 6 March 2022
Abstract Acceptance Notification 6 April 2022
Early Bird Registration Deadline 15 April 2022
Main Congress 9 - 13 June 2022